Schedule 13G ownership disclosure

Dyne Therapeutics Inc

Security class unavailable · CUSIP: 26818M108

Event date: 2024-03-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-043728
Form type
SC 13G
Filer
Dyne Therapeutics, Inc.
CIK
CIK 1818794
Filed
Apr 04, 2024
Reporting period
Mar 25, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub